Publicaciones en colaboración con investigadores/as de Hospital de Móstoles (7)

2011

  1. Gamma-aminobutyric acid GABRA4, GABRE, and GABRQ receptor polymorphisms and risk for essential tremor

    Pharmacogenetics and Genomics, Vol. 21, Núm. 7, pp. 436-439

2010

  1. Paraoxonase 1 (PON1) polymorphisms and risk for essential tremor

    European Journal of Neurology, Vol. 17, Núm. 6, pp. 879-881

2009

  1. Dopamine Receptor D3 (DRD3) genotype and allelic variants and risk for essential tremor

    Movement Disorders, Vol. 24, Núm. 13, pp. 1910-1915

2008

  1. Glutathione-S-transferase P1 polymorphism and risk for essential tremor

    European Journal of Neurology, Vol. 15, Núm. 3, pp. 234-238

  2. The nonsynonymous Thr105Ile polymorphism of the histamine N-methyltransferase is associated to the risk of developing essential tremor

    NeuroMolecular Medicine, Vol. 10, Núm. 4, pp. 356-361

2007

  1. Alcohol dehydrogenase 2 genotype and allelic variants are not associated with the risk for essential tremor

    Clinical Neuropharmacology, Vol. 30, Núm. 4, pp. 196-200

2006

  1. CYP2C19 polymorphism and risk for essential tremor

    European Neurology, Vol. 56, Núm. 2, pp. 119-123